OMB review of cannabis rescheduling could put measure at risk

seekingalpha05-01

The White House Office of Management and Budget's review of the DEA's likely reclassification of marijuana from a Class I to a Class III controlled substance could scuttle the reform, according to one...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment